186 related articles for article (PubMed ID: 4042546)
1. Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis.
Heaton A; Johnston DG; Haigh JW; Ward MK; Alberti KG; Kerr DN
Clin Sci (Lond); 1985 Oct; 69(4):449-57. PubMed ID: 4042546
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
Heaton A; Johnston DG; Burrin JM; Orskov H; Ward MK; Alberti KG; Kerr DN
Clin Sci (Lond); 1983 Nov; 65(5):539-45. PubMed ID: 6352157
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and metabolic rhythms in Cushing's syndrome.
Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
[TBL] [Abstract][Full Text] [Related]
4. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
[TBL] [Abstract][Full Text] [Related]
5. Effect of acetate on blood metabolites and glucose tolerance during haemodialysis in uraemic non-diabetic and diabetic subjects.
Akanji AO; Sacks S
Nephron; 1991; 57(2):137-43. PubMed ID: 2020339
[TBL] [Abstract][Full Text] [Related]
6. The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
Arfeen S; Goodship TH; Kirkwood A; Ward MK
Clin Nephrol; 1990 Apr; 33(4):192-99. PubMed ID: 2190721
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic beta-cell function in CAPD.
Smith WG; Hanning I; Johnston DG; Brown CB
Nephrol Dial Transplant; 1988; 3(4):448-52. PubMed ID: 3140132
[TBL] [Abstract][Full Text] [Related]
8. Sodium content and transport of white and red blood cells in undialysed uraemic and continuous ambulatory peritoneal dialysis patients.
Main J; Thomas T; Wilkinson R
Nephrol Dial Transplant; 1990; 5(5):369-75. PubMed ID: 2115628
[TBL] [Abstract][Full Text] [Related]
9. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
10. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiles in patients with insulinoma.
Hale PJ; Nattrass M
Clin Endocrinol (Oxf); 1989 Jan; 30(1):29-38. PubMed ID: 2550166
[TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities in obese patients with impaired glucose tolerance.
Robertson DA; Singh BM; Baddeley RM; Nattrass M
Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
14. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
[TBL] [Abstract][Full Text] [Related]
15. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD).
Heaton A; Ward MK; Johnston DG; Nicholson DV; Alberti KG; Kerr DN
Clin Sci (Lond); 1984 Jul; 67(1):121-30. PubMed ID: 6734073
[TBL] [Abstract][Full Text] [Related]
16. Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis.
Lindholm B; Karlander SG
Acta Med Scand; 1986; 220(5):477-83. PubMed ID: 3544691
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
18. Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis.
Heaton A; Taylor R; Johnston DG; Ward MK; Wilkinson R; Alberti KG
Clin Sci (Lond); 1989 Oct; 77(4):383-8. PubMed ID: 2680234
[TBL] [Abstract][Full Text] [Related]
19. Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis.
Sandle GI; Gaiger E; Tapster S; Goodship TH
Clin Sci (Lond); 1987 Sep; 73(3):247-52. PubMed ID: 3652631
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients.
Llopart R; Doñate T; Oliva JA; Rodá M; Rousaud F; Gonzalez-Sastre F; Pedreño J; Ordoñez-Llanos J
Nephrol Dial Transplant; 1995; 10(4):537-40. PubMed ID: 7623998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
